Cell therapies as potential treatments for Parkinson's disease first gained traction in the
1980s, owing to the clinical success of trials that used transplants of foetal midbrain …

Background A broad literature base exists for measuring medication adherence to
monotherapeutic regimens, but publications are less extensive for measuring adherence to …

Parkinson's disease (PD) is the second most common neurodegenerative disorder, after
Alzheimer's disease, affecting the elderly worldwide. Current therapy for PD is largely based …

Background: Once-daily treatment formulation is associated with better adherence in
comparison to more complex medication regimens. The study aimed to detect the extent of …

An overview of pyrroles as distinct scaffolds with therapeutic potential and the significance of
pyrrole derivatives for drug development are provided in this article. It lists instances of …

Objective Mobile app-based telerehabilitation is practical and cost-effective in neurological
rehabilitation. The present systematic review aimed to investigate the effectiveness of mobile …

Photobiomodulation (PBM) has emerged as a rapidly growing and innovative therapeutic
method for various illnesses in recent years. Due to the irreversible nature of Parkinson's …

Purpose Although therapeutic options and clinical guidelines for Parkinson's disease (PD)
have changed significantly in the past 15 years, prescribing trends in the USA remain …

Failure to comply with treatment recommendations is very common in patients, but still
poorly recognised by doctors. The current practice of using oral therapy on a large scale has …

Abstract Background Many patients with Parkinson's disease (PD) who receive
carbidopa/levodopa experience symptom reemergence or worsening, or “OFF” episodes …